IL6ST and hepatocellular carcinoma: Both these above observations appear to further support our contention that a broad blockade of pathways of multiple pro-tumorigenic cytokines by sgp130 accounts for the high efficacy of sgp130 in reducing DEN-induced HCC in the mouse and also in reducing human HCC in the xenograft mouse model.